On November 20, 2017 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), reported that it will present at the LD Micro Conference taking place December 5-7th in Los Angeles (Press release, Onconova, NOV 20, 2017, View Source [SID1234522181]). The Company’s CEO and President, Dr. Ramesh Kumar, will present and be available for one-on-one meetings.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Date: Thursday, December 7th, 2017

Time: 9:00 am PST (12:00 pm EST)

Location: Luxe Sunset Boulevard Hotel, Los Angeles, California, Track 4

The presentation will be available on the Investors section of the Company’s website at: View Source